Featured Post
How To: Nasal Rinses With CurifyLabs
Nasal rinses are widely used in the management of chronic rhinosinusitis, allergic rhinitis, and post-surgical care, where effective local delivery of anti-inflammatory agents is essential. Active ingredients such as budesonide are commonly prescribed to reduce mucosal inflammation, improve sinus drainage, and enhance patient outcomes—especially in cases where standard sprays do not provide sufficient penetration into the sinus cavities.
Revolutionierung der pharmazeutischen Behandlung mit Hilfe neuer Technologien – Fallbeispiel iGalenici in Italien
Entdecken Sie, wie 3D-Drucktechnologie die pharmazeutische Behandlung revolutioniert. Am Beispiel iGalenici zeigen wir, wie personalisierte Medizin präzise Lösungen für Krebspatienten und seltene Krankheiten bietet.
Back to the Roots: This is Where It Started!
Niklas Sandler visits Åbo Akademi University in Turku to explore the origins of CurifyLabs' CSS technology and shares nostalgic insights and scientific revelations. Tune in for more!
We are excited to join #PediatRxCon34 from April 9th-12th
We are excited to participate in the #PediatRxCon34 in Portland from April 9th to 12th!
CurifyLabs on TV Again!
Our customer Johannes Wesling Klinikum in Minden was the topic of a television report, putting the light on the use of our Pharmaprinter at their hospital.
CurifyLabs is Honored to be Presenting at #APhA2025 in Nashville
CurifyLabs honored to be presenting at #APhA2025 in Nashville, March 21–24.
Thank You, EAHP 2025!
CurifyLabs at EAHP 2025 3D Pharma printing CSS technology automated compounding
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Live From Training the Helios Erfurt Pharmacy Team!
3D printed medicines Helios Erfurt Pharmacy automated compounding technology non-sterile
Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Technology to Advance Personalized Pediatric Treatments
Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Technology to Advance Personalized Pediatric Treatments